CA2462873A1 - Molecules d'acides nucleiques et proteines issues de la tete, de la moelle epiniere, de l'intestin posterieur et du tube de malpighi de puces et utilisations correspondantes - Google Patents

Molecules d'acides nucleiques et proteines issues de la tete, de la moelle epiniere, de l'intestin posterieur et du tube de malpighi de puces et utilisations correspondantes Download PDF

Info

Publication number: CA2462873A1
Authority: CA; Canada
Prior art keywords: nucleic acid; unknown; misc; feature; protein
Prior art date: 2001-10-10
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

CA002462873A

Other languages

English (en)

Inventor

Kevin S. Brandt

Patrick J. Gaines

Dan T. Stinchcomb

Nancy Wisnewski

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Heska Corp

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-10

Filing date

2002-10-04

Publication date

2003-04-17

2002-10-04 Application filed by Individual filed Critical Individual

2003-04-17 Publication of CA2462873A1 publication Critical patent/CA2462873A1/fr

Status Abandoned legal-status Critical Current

Links

150000007523 nucleic acids Chemical class 0.000 title claims abstract description 363
108090000623 proteins and genes Proteins 0.000 title claims abstract description 328
102000004169 proteins and genes Human genes 0.000 title claims abstract description 296
108020004707 nucleic acids Proteins 0.000 title claims abstract description 288
102000039446 nucleic acids Human genes 0.000 title claims abstract description 288
210000005036 nerve Anatomy 0.000 title abstract description 18
210000003750 lower gastrointestinal tract Anatomy 0.000 title abstract description 17
210000004334 malpighian tubule Anatomy 0.000 title abstract description 17
150000001875 compounds Chemical class 0.000 claims abstract description 77
239000000203 mixture Substances 0.000 claims abstract description 70
238000000034 method Methods 0.000 claims abstract description 66
230000002401 inhibitory effect Effects 0.000 claims abstract description 32
108091028043 Nucleic acid sequence Proteins 0.000 claims description 61
230000000694 effects Effects 0.000 claims description 26
230000000295 complement effect Effects 0.000 claims description 22
241000700605 Viruses Species 0.000 claims description 20
230000022532 regulation of transcription, DNA-dependent Effects 0.000 claims description 20
230000000368 destabilizing effect Effects 0.000 claims description 13
239000003795 chemical substances by application Substances 0.000 claims description 9
230000005764 inhibitory process Effects 0.000 claims description 7
239000000546 pharmaceutical excipient Substances 0.000 claims description 7
238000005406 washing Methods 0.000 claims description 6
238000012360 testing method Methods 0.000 claims description 3
241001465754 Metazoa Species 0.000 abstract description 124
230000001225 therapeutic effect Effects 0.000 abstract description 42
208000006004 Flea Infestations Diseases 0.000 abstract description 30
230000004952 protein activity Effects 0.000 abstract description 26
230000001681 protective effect Effects 0.000 abstract description 17
108020004414 DNA Proteins 0.000 description 370
235000018102 proteins Nutrition 0.000 description 275
241000258924 Ctenocephalides felis Species 0.000 description 216
241000258922 Ctenocephalides Species 0.000 description 143
241000490229 Eucephalus Species 0.000 description 138
210000004027 cell Anatomy 0.000 description 81
150000001413 amino acids Chemical group 0.000 description 78
239000002773 nucleotide Substances 0.000 description 46
125000003729 nucleotide group Chemical group 0.000 description 46
241000282324 Felis Species 0.000 description 45
241000258242 Siphonaptera Species 0.000 description 43
210000003705 ribosome Anatomy 0.000 description 32
108020004635 Complementary DNA Proteins 0.000 description 31
239000002299 complementary DNA Substances 0.000 description 30
238000010804 cDNA synthesis Methods 0.000 description 29
238000009396 hybridization Methods 0.000 description 28
108091032973 (ribonucleotides)n+m Proteins 0.000 description 27
210000000941 bile Anatomy 0.000 description 26
239000003112 inhibitor Substances 0.000 description 23
108020004999 messenger RNA Proteins 0.000 description 22
229960005486 vaccine Drugs 0.000 description 22
241000255581 Drosophila <fruit fly, genus> Species 0.000 description 19
241001599018 Melanogaster Species 0.000 description 19
210000001519 tissue Anatomy 0.000 description 17
230000004927 fusion Effects 0.000 description 16
239000000758 substrate Substances 0.000 description 16
239000013598 vector Substances 0.000 description 16
238000006243 chemical reaction Methods 0.000 description 15
238000012163 sequencing technique Methods 0.000 description 15
108091034117 Oligonucleotide Proteins 0.000 description 14
239000012634 fragment Substances 0.000 description 13
230000028993 immune response Effects 0.000 description 13
238000003752 polymerase chain reaction Methods 0.000 description 13
230000014616 translation Effects 0.000 description 13
230000006870 function Effects 0.000 description 12
229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 12
239000000243 solution Substances 0.000 description 12
230000014509 gene expression Effects 0.000 description 11
238000004519 manufacturing process Methods 0.000 description 11
BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 11
238000013519 translation Methods 0.000 description 11
210000004369 blood Anatomy 0.000 description 10
239000008280 blood Substances 0.000 description 10
239000013604 expression vector Substances 0.000 description 10
238000009472 formulation Methods 0.000 description 10
108090000765 processed proteins & peptides Proteins 0.000 description 10
108091026890 Coding region Proteins 0.000 description 9
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 9
238000013270 controlled release Methods 0.000 description 9
230000001105 regulatory effect Effects 0.000 description 9
238000003786 synthesis reaction Methods 0.000 description 9
239000002671 adjuvant Substances 0.000 description 8
230000015572 biosynthetic process Effects 0.000 description 8
230000002068 genetic effect Effects 0.000 description 8
230000004048 modification Effects 0.000 description 8
238000012986 modification Methods 0.000 description 8
241000238631 Hexapoda Species 0.000 description 7
206010061217 Infestation Diseases 0.000 description 7
108700026244 Open Reading Frames Proteins 0.000 description 7
201000010099 disease Diseases 0.000 description 7
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
239000013612 plasmid Substances 0.000 description 7
150000003839 salts Chemical class 0.000 description 7
238000012216 screening Methods 0.000 description 7
241000710929 Alphavirus Species 0.000 description 6
241000282326 Felis catus Species 0.000 description 6
241000282414 Homo sapiens Species 0.000 description 6
108020004511 Recombinant DNA Proteins 0.000 description 6
230000001580 bacterial effect Effects 0.000 description 6
229940030156 cell vaccine Drugs 0.000 description 6
239000002609 medium Substances 0.000 description 6
239000012528 membrane Substances 0.000 description 6
239000003595 mist Substances 0.000 description 6
230000008569 process Effects 0.000 description 6
229940121649 protein inhibitor Drugs 0.000 description 6
239000012268 protein inhibitor Substances 0.000 description 6
238000000746 purification Methods 0.000 description 6
241000894007 species Species 0.000 description 6
239000003981 vehicle Substances 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
108010085238 Actins Proteins 0.000 description 5
102000007469 Actins Human genes 0.000 description 5
239000006137 Luria-Bertani broth Substances 0.000 description 5
241000699666 Mus <mouse, genus> Species 0.000 description 5
108090000854 Oxidoreductases Proteins 0.000 description 5
102000004316 Oxidoreductases Human genes 0.000 description 5
240000004808 Saccharomyces cerevisiae Species 0.000 description 5
230000037396 body weight Effects 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
-1 mimetopes Proteins 0.000 description 5
230000001629 suppression Effects 0.000 description 5
101710125089 Bindin Proteins 0.000 description 4
241000255601 Drosophila melanogaster Species 0.000 description 4
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 4
102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 4
206010020751 Hypersensitivity Diseases 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
238000001042 affinity chromatography Methods 0.000 description 4
230000003321 amplification Effects 0.000 description 4
238000003556 assay Methods 0.000 description 4
239000003153 chemical reaction reagent Substances 0.000 description 4
238000010367 cloning Methods 0.000 description 4
238000004590 computer program Methods 0.000 description 4
238000012258 culturing Methods 0.000 description 4
230000007423 decrease Effects 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
238000001514 detection method Methods 0.000 description 4
229940079593 drug Drugs 0.000 description 4
239000003814 drug Substances 0.000 description 4
238000000855 fermentation Methods 0.000 description 4
230000004151 fermentation Effects 0.000 description 4
108020001507 fusion proteins Proteins 0.000 description 4
102000037865 fusion proteins Human genes 0.000 description 4
210000000087 hemolymph Anatomy 0.000 description 4
238000003780 insertion Methods 0.000 description 4
230000037431 insertion Effects 0.000 description 4
238000002955 isolation Methods 0.000 description 4
210000003292 kidney cell Anatomy 0.000 description 4
210000004962 mammalian cell Anatomy 0.000 description 4
239000000463 material Substances 0.000 description 4
210000003205 muscle Anatomy 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
230000036961 partial effect Effects 0.000 description 4
102000004196 processed proteins & peptides Human genes 0.000 description 4
230000004044 response Effects 0.000 description 4
239000000523 sample Substances 0.000 description 4
239000000126 substance Substances 0.000 description 4
241001529453 unidentified herpesvirus Species 0.000 description 4
239000013603 viral vector Substances 0.000 description 4
DLZKEQQWXODGGZ-KCJUWKMLSA-N 2-[[(2r)-2-[[(2s)-2-amino-3-(4-hydroxyphenyl)propanoyl]amino]propanoyl]amino]acetic acid Chemical compound OC(=O)CNC(=O)[C@@H](C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 DLZKEQQWXODGGZ-KCJUWKMLSA-N 0.000 description 3
241000894006 Bacteria Species 0.000 description 3
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 3
239000005996 Blood meal Substances 0.000 description 3
241000282472 Canis lupus familiaris Species 0.000 description 3
108090000565 Capsid Proteins Proteins 0.000 description 3
241000255580 Ceratitis <genus> Species 0.000 description 3
241000196324 Embryophyta Species 0.000 description 3
108091092195 Intron Proteins 0.000 description 3
241001657712 Itata Species 0.000 description 3
241000699660 Mus musculus Species 0.000 description 3
108010029485 Protein Isoforms Proteins 0.000 description 3
102000001708 Protein Isoforms Human genes 0.000 description 3
241001675082 Pulex Species 0.000 description 3
241000700638 Raccoonpox virus Species 0.000 description 3
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
102000004243 Tubulin Human genes 0.000 description 3
108090000704 Tubulin Proteins 0.000 description 3
239000000427 antigen Substances 0.000 description 3
108091007433 antigens Proteins 0.000 description 3
102000036639 antigens Human genes 0.000 description 3
239000002246 antineoplastic agent Substances 0.000 description 3
230000001413 cellular effect Effects 0.000 description 3
229940044683 chemotherapy drug Drugs 0.000 description 3
210000000349 chromosome Anatomy 0.000 description 3
230000001276 controlling effect Effects 0.000 description 3
JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 3
239000002254 cytotoxic agent Substances 0.000 description 3
229940127089 cytotoxic agent Drugs 0.000 description 3
231100000599 cytotoxic agent Toxicity 0.000 description 3
238000012217 deletion Methods 0.000 description 3
230000037430 deletion Effects 0.000 description 3
238000011161 development Methods 0.000 description 3
230000018109 developmental process Effects 0.000 description 3
239000003623 enhancer Substances 0.000 description 3
210000003608 fece Anatomy 0.000 description 3
YQOKLYTXVFAUCW-UHFFFAOYSA-N guanidine;isothiocyanic acid Chemical compound N=C=S.NC(N)=N YQOKLYTXVFAUCW-UHFFFAOYSA-N 0.000 description 3
230000001965 increasing effect Effects 0.000 description 3
230000000977 initiatory effect Effects 0.000 description 3
238000002347 injection Methods 0.000 description 3
239000007924 injection Substances 0.000 description 3
230000002452 interceptive effect Effects 0.000 description 3
238000007918 intramuscular administration Methods 0.000 description 3
239000007788 liquid Substances 0.000 description 3
239000012139 lysis buffer Substances 0.000 description 3
229910052751 metal Inorganic materials 0.000 description 3
239000002184 metal Substances 0.000 description 3
210000003470 mitochondria Anatomy 0.000 description 3
239000006225 natural substrate Substances 0.000 description 3
210000000056 organ Anatomy 0.000 description 3
244000045947 parasite Species 0.000 description 3
230000004853 protein function Effects 0.000 description 3
229940126583 recombinant protein vaccine Drugs 0.000 description 3
238000011084 recovery Methods 0.000 description 3
230000010076 replication Effects 0.000 description 3
230000035939 shock Effects 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
239000007787 solid Substances 0.000 description 3
238000007920 subcutaneous administration Methods 0.000 description 3
238000006467 substitution reaction Methods 0.000 description 3
238000013518 transcription Methods 0.000 description 3
230000035897 transcription Effects 0.000 description 3
230000009466 transformation Effects 0.000 description 3
241000701161 unidentified adenovirus Species 0.000 description 3
241001430294 unidentified retrovirus Species 0.000 description 3
230000035899 viability Effects 0.000 description 3
230000003612 virological effect Effects 0.000 description 3
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 2
241000256111 Aedes <genus> Species 0.000 description 2
108010011170 Ala-Trp-Arg-His-Pro-Gln-Phe-Gly-Gly Proteins 0.000 description 2
108700028369 Alleles Proteins 0.000 description 2
108020005544 Antisense RNA Proteins 0.000 description 2
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
108090000994 Catalytic RNA Proteins 0.000 description 2
102000053642 Catalytic RNA Human genes 0.000 description 2
102000019034 Chemokines Human genes 0.000 description 2
108010012236 Chemokines Proteins 0.000 description 2
108700010070 Codon Usage Proteins 0.000 description 2
108010071942 Colony-Stimulating Factors Proteins 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
241000701022 Cytomegalovirus Species 0.000 description 2
101000645318 Drosophila melanogaster Titin Proteins 0.000 description 2
241000701832 Enterobacteria phage T3 Species 0.000 description 2
102000004190 Enzymes Human genes 0.000 description 2
108090000790 Enzymes Proteins 0.000 description 2
102000003951 Erythropoietin Human genes 0.000 description 2
108090000394 Erythropoietin Proteins 0.000 description 2
241000588724 Escherichia coli Species 0.000 description 2
108700024394 Exon Proteins 0.000 description 2
101710157275 Ferritin subunit Proteins 0.000 description 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
241000287826 Gallus Species 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
102000004269 Granulocyte Colony-Stimulating Factor Human genes 0.000 description 2
108010017080 Granulocyte Colony-Stimulating Factor Proteins 0.000 description 2
108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
241000198834 Heliophorus ila Species 0.000 description 2
241000282412 Homo Species 0.000 description 2
108060003951 Immunoglobulin Proteins 0.000 description 2
102000014150 Interferons Human genes 0.000 description 2
108010050904 Interferons Proteins 0.000 description 2
102000013462 Interleukin-12 Human genes 0.000 description 2
108010065805 Interleukin-12 Proteins 0.000 description 2
102100039898 Interleukin-18 Human genes 0.000 description 2
102000000588 Interleukin-2 Human genes 0.000 description 2
108010002350 Interleukin-2 Proteins 0.000 description 2
102000000646 Interleukin-3 Human genes 0.000 description 2
108010002386 Interleukin-3 Proteins 0.000 description 2
102000004889 Interleukin-6 Human genes 0.000 description 2
108090001005 Interleukin-6 Proteins 0.000 description 2
102000000704 Interleukin-7 Human genes 0.000 description 2
108010002586 Interleukin-7 Proteins 0.000 description 2
102000004890 Interleukin-8 Human genes 0.000 description 2
108090001007 Interleukin-8 Proteins 0.000 description 2
102000015696 Interleukins Human genes 0.000 description 2
108010063738 Interleukins Proteins 0.000 description 2
241000186781 Listeria Species 0.000 description 2
102000007651 Macrophage Colony-Stimulating Factor Human genes 0.000 description 2
108010046938 Macrophage Colony-Stimulating Factor Proteins 0.000 description 2
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 2
241000255908 Manduca sexta Species 0.000 description 2
101710151805 Mitochondrial intermediate peptidase 1 Proteins 0.000 description 2
102100027869 Moesin Human genes 0.000 description 2
241000257159 Musca domestica Species 0.000 description 2
241000282339 Mustela Species 0.000 description 2
241000376509 Nosopsyllus Species 0.000 description 2
238000012408 PCR amplification Methods 0.000 description 2
229910019142 PO4 Inorganic materials 0.000 description 2
241000709664 Picornaviridae Species 0.000 description 2
206010035226 Plasma cell myeloma Diseases 0.000 description 2
102100035181 Plastin-1 Human genes 0.000 description 2
241000700157 Rattus norvegicus Species 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
241000714474 Rous sarcoma virus Species 0.000 description 2
238000012300 Sequence Analysis Methods 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
241000710960 Sindbis virus Species 0.000 description 2
241000256248 Spodoptera Species 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
241000255985 Trichoplusia Species 0.000 description 2
241000195614 Volvox carteri Species 0.000 description 2
230000003187 abdominal effect Effects 0.000 description 2
230000006978 adaptation Effects 0.000 description 2
208000026935 allergic disease Diseases 0.000 description 2
230000007815 allergy Effects 0.000 description 2
230000004075 alteration Effects 0.000 description 2
AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 2
229960000723 ampicillin Drugs 0.000 description 2
235000021120 animal protein Nutrition 0.000 description 2
238000003149 assay kit Methods 0.000 description 2
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
230000002238 attenuated effect Effects 0.000 description 2
208000036815 beta tubulin Diseases 0.000 description 2
238000010805 cDNA synthesis kit Methods 0.000 description 2
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
210000002421 cell wall Anatomy 0.000 description 2
238000003776 cleavage reaction Methods 0.000 description 2
239000003184 complementary RNA Substances 0.000 description 2
230000009089 cytolysis Effects 0.000 description 2
244000078703 ectoparasite Species 0.000 description 2
235000013601 eggs Nutrition 0.000 description 2
230000002708 enhancing effect Effects 0.000 description 2
229940105423 erythropoietin Drugs 0.000 description 2
230000004634 feeding behavior Effects 0.000 description 2
210000002950 fibroblast Anatomy 0.000 description 2
230000002538 fungal effect Effects 0.000 description 2
150000004820 halides Chemical class 0.000 description 2
230000036541 health Effects 0.000 description 2
230000002163 immunogen Effects 0.000 description 2
102000018358 immunoglobulin Human genes 0.000 description 2
238000011534 incubation Methods 0.000 description 2
239000012678 infectious agent Substances 0.000 description 2
230000003993 interaction Effects 0.000 description 2
229940117681 interleukin-12 Drugs 0.000 description 2
229940076264 interleukin-3 Drugs 0.000 description 2
229940100601 interleukin-6 Drugs 0.000 description 2
229940100994 interleukin-7 Drugs 0.000 description 2
229940096397 interleukin-8 Drugs 0.000 description 2
XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 description 2
150000002500 ions Chemical class 0.000 description 2
230000001418 larval effect Effects 0.000 description 2
239000002502 liposome Substances 0.000 description 2
239000006166 lysate Substances 0.000 description 2
230000003278 mimic effect Effects 0.000 description 2
108010071525 moesin Proteins 0.000 description 2
229940031348 multivalent vaccine Drugs 0.000 description 2
238000002703 mutagenesis Methods 0.000 description 2
231100000350 mutagenesis Toxicity 0.000 description 2
230000035772 mutation Effects 0.000 description 2
201000000050 myeloid neoplasm Diseases 0.000 description 2
210000003098 myoblast Anatomy 0.000 description 2
235000015097 nutrients Nutrition 0.000 description 2
QWVGKYWNOKOFNN-UHFFFAOYSA-N o-cresol Chemical compound CC1=CC=CC=C1O QWVGKYWNOKOFNN-UHFFFAOYSA-N 0.000 description 2
238000005457 optimization Methods 0.000 description 2
229910052760 oxygen Inorganic materials 0.000 description 2
239000001301 oxygen Substances 0.000 description 2
239000000575 pesticide Substances 0.000 description 2
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
239000010452 phosphate Substances 0.000 description 2
238000013492 plasmid preparation Methods 0.000 description 2
108010049148 plastin Proteins 0.000 description 2
230000004481 post-translational protein modification Effects 0.000 description 2
102000035123 post-translationally modified proteins Human genes 0.000 description 2
108091005626 post-translationally modified proteins Proteins 0.000 description 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 2
239000003755 preservative agent Substances 0.000 description 2
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
239000013615 primer Substances 0.000 description 2
229940023143 protein vaccine Drugs 0.000 description 2
238000003753 real-time PCR Methods 0.000 description 2
230000000717 retained effect Effects 0.000 description 2
108091092562 ribozyme Proteins 0.000 description 2
230000007017 scission Effects 0.000 description 2
239000004544 spot-on Substances 0.000 description 2
238000005507 spraying Methods 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
VNOYUJKHFWYWIR-ITIYDSSPSA-N succinyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC(O)=O)O[C@H]1N1C2=NC=NC(N)=C2N=C1 VNOYUJKHFWYWIR-ITIYDSSPSA-N 0.000 description 2
239000000725 suspension Substances 0.000 description 2
229960000187 tissue plasminogen activator Drugs 0.000 description 2
230000000699 topical effect Effects 0.000 description 2
230000001131 transforming effect Effects 0.000 description 2
230000009261 transgenic effect Effects 0.000 description 2
210000003501 vero cell Anatomy 0.000 description 2
DIGQNXIGRZPYDK-WKSCXVIASA-N (2R)-6-amino-2-[[2-[[(2S)-2-[[2-[[(2R)-2-[[(2S)-2-[[(2R,3S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S,3S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[(2R)-2-[[2-[[2-[[2-[(2-amino-1-hydroxyethylidene)amino]-3-carboxy-1-hydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxypropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1,5-dihydroxy-5-iminopentylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxybutylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1,3-dihydroxypropylidene]amino]-1-hydroxyethylidene]amino]-1-hydroxy-3-sulfanylpropylidene]amino]-1-hydroxyethylidene]amino]hexanoic acid Chemical compound C[C@@H]([C@@H](C(=N[C@@H](CS)C(=N[C@@H](C)C(=N[C@@H](CO)C(=NCC(=N[C@@H](CCC(=N)O)C(=NC(CS)C(=N[C@H]([C@H](C)O)C(=N[C@H](CS)C(=N[C@H](CO)C(=NCC(=N[C@H](CS)C(=NCC(=N[C@H](CCCCN)C(=O)O)O)O)O)O)O)O)O)O)O)O)O)O)O)N=C([C@H](CS)N=C([C@H](CO)N=C([C@H](CO)N=C([C@H](C)N=C(CN=C([C@H](CO)N=C([C@H](CS)N=C(CN=C(C(CS)N=C(C(CC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O)O)O)O DIGQNXIGRZPYDK-WKSCXVIASA-N 0.000 description 1
SBKVPJHMSUXZTA-MEJXFZFPSA-N (2S)-2-[[(2S)-2-[[(2S)-1-[(2S)-5-amino-2-[[2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-imidazol-4-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-4-methylpentanoyl]amino]-5-oxopentanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]acetyl]amino]-5-oxopentanoyl]pyrrolidine-2-carbonyl]amino]-4-methylsulfanylbutanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 SBKVPJHMSUXZTA-MEJXFZFPSA-N 0.000 description 1
PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 1
102100037149 3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial Human genes 0.000 description 1
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
102100036630 60S ribosomal protein L7a Human genes 0.000 description 1
102000023805 ATP:ADP antiporter activity proteins Human genes 0.000 description 1
108040000931 ATP:ADP antiporter activity proteins Proteins 0.000 description 1
108091006112 ATPases Proteins 0.000 description 1
RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
108010009924 Aconitate hydratase Proteins 0.000 description 1
102000057290 Adenosine Triphosphatases Human genes 0.000 description 1
241000256173 Aedes albopictus Species 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
108010025188 Alcohol oxidase Proteins 0.000 description 1
241000237370 Aplysia californica Species 0.000 description 1
241000238582 Artemia Species 0.000 description 1
241000238421 Arthropoda Species 0.000 description 1
241000193830 Bacillus <bacterium> Species 0.000 description 1
241000702194 Bacillus virus SPO1 Species 0.000 description 1
241001222008 Beamys hindei Species 0.000 description 1
102000004506 Blood Proteins Human genes 0.000 description 1
108010017384 Blood Proteins Proteins 0.000 description 1
241000255791 Bombyx Species 0.000 description 1
241000255789 Bombyx mori Species 0.000 description 1
238000009631 Broth culture Methods 0.000 description 1
101150000595 CLMP gene Proteins 0.000 description 1
241000244202 Caenorhabditis Species 0.000 description 1
101100097220 Caenorhabditis elegans sft-4 gene Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
102100029968 Calreticulin Human genes 0.000 description 1
108090000549 Calreticulin Proteins 0.000 description 1
241000282465 Canis Species 0.000 description 1
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
241000863012 Caulobacter Species 0.000 description 1
108010067225 Cell Adhesion Molecules Proteins 0.000 description 1
102000016289 Cell Adhesion Molecules Human genes 0.000 description 1
241000282693 Cercopithecidae Species 0.000 description 1
241000256128 Chironomus <genus> Species 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
101710176457 Citrate lyase alpha chain Proteins 0.000 description 1
244000205754 Colocasia esculenta Species 0.000 description 1
235000006481 Colocasia esculenta Nutrition 0.000 description 1
102000000989 Complement System Proteins Human genes 0.000 description 1
108010069112 Complement System Proteins Proteins 0.000 description 1
108010062580 Concanavalin A Proteins 0.000 description 1
241000699800 Cricetinae Species 0.000 description 1
241000134316 Culicoides <genus> Species 0.000 description 1
108010052832 Cytochromes Proteins 0.000 description 1
102000018832 Cytochromes Human genes 0.000 description 1
102100039868 Cytoplasmic aconitate hydratase Human genes 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
102000053602 DNA Human genes 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
201000004624 Dermatitis Diseases 0.000 description 1
229920002307 Dextran Polymers 0.000 description 1
241000168726 Dictyostelium discoideum Species 0.000 description 1
108700004970 Drosophila Hmu Proteins 0.000 description 1
101100382322 Drosophila melanogaster Acam gene Proteins 0.000 description 1
101100372839 Drosophila melanogaster vanin-like gene Proteins 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
101710083262 Ectin Proteins 0.000 description 1
LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
241000283086 Equidae Species 0.000 description 1
241001646716 Escherichia coli K-12 Species 0.000 description 1
241000701959 Escherichia virus Lambda Species 0.000 description 1
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
102100029782 Eukaryotic translation initiation factor 3 subunit I Human genes 0.000 description 1
101710109054 Eukaryotic translation initiation factor 3 subunit I Proteins 0.000 description 1
102100020903 Ezrin Human genes 0.000 description 1
108010087819 Fc receptors Proteins 0.000 description 1
102000009109 Fc receptors Human genes 0.000 description 1
108050000784 Ferritin Proteins 0.000 description 1
102000008857 Ferritin Human genes 0.000 description 1
238000008416 Ferritin Methods 0.000 description 1
241000287828 Gallus gallus Species 0.000 description 1
208000003098 Ganglion Cysts Diseases 0.000 description 1
108010051696 Growth Hormone Proteins 0.000 description 1
NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
101000592773 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) 50S ribosomal protein L22 Proteins 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
241000255967 Helicoverpa zea Species 0.000 description 1
108010034145 Helminth Proteins Proteins 0.000 description 1
102000006479 Heterogeneous-Nuclear Ribonucleoproteins Human genes 0.000 description 1
108010019372 Heterogeneous-Nuclear Ribonucleoproteins Proteins 0.000 description 1
SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
101001098439 Homo sapiens 3-oxoacyl-[acyl-carrier-protein] synthase, mitochondrial Proteins 0.000 description 1
101000853243 Homo sapiens 60S ribosomal protein L7a Proteins 0.000 description 1
101000686246 Homo sapiens Ras-related protein R-Ras Proteins 0.000 description 1
102000008100 Human Serum Albumin Human genes 0.000 description 1
108091006905 Human Serum Albumin Proteins 0.000 description 1
241000243251 Hydra Species 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
206010061218 Inflammation Diseases 0.000 description 1
102000008070 Interferon-gamma Human genes 0.000 description 1
108010074328 Interferon-gamma Proteins 0.000 description 1
102000003814 Interleukin-10 Human genes 0.000 description 1
108090000174 Interleukin-10 Proteins 0.000 description 1
108090000171 Interleukin-18 Proteins 0.000 description 1
102000004388 Interleukin-4 Human genes 0.000 description 1
108090000978 Interleukin-4 Proteins 0.000 description 1
102000000743 Interleukin-5 Human genes 0.000 description 1
108010002616 Interleukin-5 Proteins 0.000 description 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
241000222722 Leishmania <genus> Species 0.000 description 1
102000003960 Ligases Human genes 0.000 description 1
108090000364 Ligases Proteins 0.000 description 1
241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
102000009571 Macrophage Inflammatory Proteins Human genes 0.000 description 1
108010009474 Macrophage Inflammatory Proteins Proteins 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
108010038049 Mating Factor Proteins 0.000 description 1
241001405846 Mauritiana Species 0.000 description 1
241001422926 Mayetiola hordei Species 0.000 description 1
102000003792 Metallothionein Human genes 0.000 description 1
108090000157 Metallothionein Proteins 0.000 description 1
108010063954 Mucins Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
101100420730 Mus musculus Sec23a gene Proteins 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
102000003505 Myosin Human genes 0.000 description 1
108060008487 Myosin Proteins 0.000 description 1
102000005604 Myosin Heavy Chains Human genes 0.000 description 1
108010084498 Myosin Heavy Chains Proteins 0.000 description 1
108010028277 Myosin Type I Proteins 0.000 description 1
101150034114 ND5 gene Proteins 0.000 description 1
229910002651 NO3 Inorganic materials 0.000 description 1
108091061960 Naked DNA Proteins 0.000 description 1
241000244206 Nematoda Species 0.000 description 1
108010085839 Neurofibromin 2 Proteins 0.000 description 1
102000007517 Neurofibromin 2 Human genes 0.000 description 1
NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
238000000636 Northern blotting Methods 0.000 description 1
108700001237 Nucleic Acid-Based Vaccines Proteins 0.000 description 1
108091005461 Nucleic proteins Chemical group 0.000 description 1
108020005187 Oligonucleotide Probes Proteins 0.000 description 1
241000243985 Onchocerca volvulus Species 0.000 description 1
241000208631 Oropsylla Species 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
241001494479 Pecora Species 0.000 description 1
108010044843 Peptide Initiation Factors Proteins 0.000 description 1
102000005877 Peptide Initiation Factors Human genes 0.000 description 1
102000012288 Phosphopyruvate Hydratase Human genes 0.000 description 1
108010022181 Phosphopyruvate Hydratase Proteins 0.000 description 1
241000235648 Pichia Species 0.000 description 1
241000257453 Pisaster ochraceus Species 0.000 description 1
241000237511 Placopecten Species 0.000 description 1
241000224016 Plasmodium Species 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
102000006010 Protein Disulfide-Isomerase Human genes 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
240000008296 Prunus serotina Species 0.000 description 1
235000014441 Prunus serotina Nutrition 0.000 description 1
102100022127 Radixin Human genes 0.000 description 1
102100024683 Ras-related protein R-Ras Human genes 0.000 description 1
108090000783 Renin Proteins 0.000 description 1
102100028255 Renin Human genes 0.000 description 1
241001468001 Salmonella virus SP6 Species 0.000 description 1
241000710961 Semliki Forest virus Species 0.000 description 1
102000012479 Serine Proteases Human genes 0.000 description 1
108010022999 Serine Proteases Proteins 0.000 description 1
102100038803 Somatotropin Human genes 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000256251 Spodoptera frugiperda Species 0.000 description 1
241000251576 Styela clava Species 0.000 description 1
101150041750 Surf4 gene Proteins 0.000 description 1
102100026355 Surfeit locus protein 4 Human genes 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
208000005400 Synovial Cyst Diseases 0.000 description 1
108091008874 T cell receptors Proteins 0.000 description 1
102000016266 T-Cell Antigen Receptors Human genes 0.000 description 1
108091036066 Three prime untranslated region Proteins 0.000 description 1
ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
101710120037 Toxin CcdB Proteins 0.000 description 1
108090000992 Transferases Proteins 0.000 description 1
102000004357 Transferases Human genes 0.000 description 1
102000004887 Transforming Growth Factor beta Human genes 0.000 description 1
108090001012 Transforming Growth Factor beta Proteins 0.000 description 1
241000869417 Trematodes Species 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
101710120473 Tubulin beta-5 chain Proteins 0.000 description 1
108090000848 Ubiquitin Proteins 0.000 description 1
102000044159 Ubiquitin Human genes 0.000 description 1
241000219871 Ulex Species 0.000 description 1
102100026776 Unconventional myosin-Ib Human genes 0.000 description 1
241000700618 Vaccinia virus Species 0.000 description 1
102000005456 Vesicular Transport Adaptor Proteins Human genes 0.000 description 1
108010031770 Vesicular Transport Adaptor Proteins Proteins 0.000 description 1
108010003533 Viral Envelope Proteins Proteins 0.000 description 1
UZQJVUCHXGYFLQ-AYDHOLPZSA-N [(2s,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-4-[(2r,3r,4s,5r,6r)-4-[(2s,3r,4s,5r,6r)-3,5-dihydroxy-6-(hydroxymethyl)-4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,5-dihydroxy-6-(hy Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O)O[C@H]1CC[C@]2(C)[C@H]3CC=C4[C@@]([C@@]3(CC[C@H]2[C@@]1(C=O)C)C)(C)CC(O)[C@]1(CCC(CC14)(C)C)C(=O)O[C@H]1[C@@H]([C@@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O[C@H]4[C@@H]([C@@H](O[C@H]5[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O5)O)[C@H](O)[C@@H](CO)O4)O)[C@H](O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UZQJVUCHXGYFLQ-AYDHOLPZSA-N 0.000 description 1
XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
230000021736 acetylation Effects 0.000 description 1
238000006640 acetylation reaction Methods 0.000 description 1
229940127024 acid based drug Drugs 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000009056 active transport Effects 0.000 description 1
239000000654 additive Substances 0.000 description 1
230000002411 adverse Effects 0.000 description 1
239000008272 agar Substances 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
230000000172 allergic effect Effects 0.000 description 1
230000003281 allosteric effect Effects 0.000 description 1
230000008841 allosteric interaction Effects 0.000 description 1
150000004716 alpha keto acids Chemical class 0.000 description 1
102000012086 alpha-L-Fucosidase Human genes 0.000 description 1
108010061314 alpha-L-Fucosidase Proteins 0.000 description 1
229910052782 aluminium Inorganic materials 0.000 description 1
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
230000009435 amidation Effects 0.000 description 1
238000007112 amidation reaction Methods 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000012736 aqueous medium Substances 0.000 description 1
208000010668 atopic eczema Diseases 0.000 description 1
210000003050 axon Anatomy 0.000 description 1
210000003719 b-lymphocyte Anatomy 0.000 description 1
239000003855 balanced salt solution Substances 0.000 description 1
230000003542 behavioural effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
235000019445 benzyl alcohol Nutrition 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
229920000249 biocompatible polymer Polymers 0.000 description 1
229920001400 block copolymer Polymers 0.000 description 1
230000000903 blocking effect Effects 0.000 description 1
210000004556 brain Anatomy 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000007853 buffer solution Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000002775 capsule Substances 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
235000014633 carbohydrates Nutrition 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
229960004203 carnitine Drugs 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000015556 catabolic process Effects 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
239000013592 cell lysate Substances 0.000 description 1
230000007969 cellular immunity Effects 0.000 description 1
238000001311 chemical methods and process Methods 0.000 description 1
230000000723 chemosensory effect Effects 0.000 description 1
210000004978 chinese hamster ovary cell Anatomy 0.000 description 1
238000011098 chromatofocusing Methods 0.000 description 1
238000004587 chromatography analysis Methods 0.000 description 1
238000012411 cloning technique Methods 0.000 description 1
RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
239000005516 coenzyme A Substances 0.000 description 1
229940093530 coenzyme a Drugs 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
210000002251 corpora allata Anatomy 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
108010036495 cytochrome P-450 CYP12A3 Proteins 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
238000006731 degradation reaction Methods 0.000 description 1
238000002716 delivery method Methods 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
239000008121 dextrose Substances 0.000 description 1
238000009792 diffusion process Methods 0.000 description 1
230000029087 digestion Effects 0.000 description 1
238000007865 diluting Methods 0.000 description 1
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
238000004520 electroporation Methods 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
229940096118 ella Drugs 0.000 description 1
230000002124 endocrine Effects 0.000 description 1
230000007368 endocrine function Effects 0.000 description 1
244000079386 endoparasite Species 0.000 description 1
239000002158 endotoxin Substances 0.000 description 1
150000002148 esters Chemical class 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
229940093471 ethyl oleate Drugs 0.000 description 1
210000003527 eukaryotic cell Anatomy 0.000 description 1
230000029142 excretion Effects 0.000 description 1
231100000776 exotoxin Toxicity 0.000 description 1
239000002095 exotoxin Substances 0.000 description 1
108010055671 ezrin Proteins 0.000 description 1
230000035611 feeding Effects 0.000 description 1
NYPJDWWKZLNGGM-UHFFFAOYSA-N fenvalerate Chemical compound C=1C=C(Cl)C=CC=1C(C(C)C)C(=O)OC(C#N)C(C=1)=CC=CC=1OC1=CC=CC=C1 NYPJDWWKZLNGGM-UHFFFAOYSA-N 0.000 description 1
230000035558 fertility Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000007667 floating Methods 0.000 description 1
108700014844 flt3 ligand Proteins 0.000 description 1
235000013305 food Nutrition 0.000 description 1
BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 1
210000000609 ganglia Anatomy 0.000 description 1
239000000499 gel Substances 0.000 description 1
238000001641 gel filtration chromatography Methods 0.000 description 1
150000002334 glycols Chemical class 0.000 description 1
230000013595 glycosylation Effects 0.000 description 1
238000006206 glycosylation reaction Methods 0.000 description 1
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
239000010931 gold Substances 0.000 description 1
229910052737 gold Inorganic materials 0.000 description 1
230000012010 growth Effects 0.000 description 1
239000000122 growth hormone Substances 0.000 description 1
108010048004 helix-destabilizing proteins Proteins 0.000 description 1
244000000013 helminth Species 0.000 description 1
125000005842 heteroatom Chemical group 0.000 description 1
230000003301 hydrolyzing effect Effects 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
238000003018 immunoassay Methods 0.000 description 1
238000003119 immunoblot Methods 0.000 description 1
230000005847 immunogenicity Effects 0.000 description 1
239000002955 immunomodulating agent Substances 0.000 description 1
230000000091 immunopotentiator Effects 0.000 description 1
239000007943 implant Substances 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
230000004054 inflammatory process Effects 0.000 description 1
229910052500 inorganic mineral Inorganic materials 0.000 description 1
229960000367 inositol Drugs 0.000 description 1
CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
239000002917 insecticide Substances 0.000 description 1
230000010354 integration Effects 0.000 description 1
229940079322 interferon Drugs 0.000 description 1
229960003130 interferon gamma Drugs 0.000 description 1
229940047124 interferons Drugs 0.000 description 1
229940076144 interleukin-10 Drugs 0.000 description 1
229940028885 interleukin-4 Drugs 0.000 description 1
229940100602 interleukin-5 Drugs 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
229940065638 intron a Drugs 0.000 description 1
238000004255 ion exchange chromatography Methods 0.000 description 1
ODBLHEXUDAPZAU-UHFFFAOYSA-N isocitric acid Chemical compound OC(=O)C(O)C(C(O)=O)CC(O)=O ODBLHEXUDAPZAU-UHFFFAOYSA-N 0.000 description 1
FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
QRXWMOHMRWLFEY-UHFFFAOYSA-N isoniazide Chemical compound NNC(=O)C1=CC=NC=C1 QRXWMOHMRWLFEY-UHFFFAOYSA-N 0.000 description 1
238000005304 joining Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
150000002632 lipids Chemical class 0.000 description 1
238000001638 lipofection Methods 0.000 description 1
239000012669 liquid formulation Substances 0.000 description 1
229940049920 malate Drugs 0.000 description 1
BJEPYKJPYRNKOW-UHFFFAOYSA-N malic acid Chemical compound OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
210000001161 mammalian embryo Anatomy 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000035800 maturation Effects 0.000 description 1
238000002844 melting Methods 0.000 description 1
230000008018 melting Effects 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
230000029052 metamorphosis Effects 0.000 description 1
229930182817 methionine Natural products 0.000 description 1
239000003094 microcapsule Substances 0.000 description 1
238000000520 microinjection Methods 0.000 description 1
239000011859 microparticle Substances 0.000 description 1
239000011707 mineral Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
238000000302 molecular modelling Methods 0.000 description 1
230000007498 myristoylation Effects 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
208000002761 neurofibromatosis 2 Diseases 0.000 description 1
208000022032 neurofibromatosis type 2 Diseases 0.000 description 1
230000003955 neuronal function Effects 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
239000002687 nonaqueous vehicle Substances 0.000 description 1
231100001221 nontumorigenic Toxicity 0.000 description 1
239000000346 nonvolatile oil Substances 0.000 description 1
229940023146 nucleic acid vaccine Drugs 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
239000003921 oil Substances 0.000 description 1
235000019198 oils Nutrition 0.000 description 1
239000002751 oligonucleotide probe Substances 0.000 description 1
230000003204 osmotic effect Effects 0.000 description 1
230000026792 palmitoylation Effects 0.000 description 1
230000009057 passive transport Effects 0.000 description 1
239000000816 peptidomimetic Substances 0.000 description 1
210000001322 periplasm Anatomy 0.000 description 1
239000008363 phosphate buffer Substances 0.000 description 1
239000002953 phosphate buffered saline Substances 0.000 description 1
230000026731 phosphorylation Effects 0.000 description 1
238000006366 phosphorylation reaction Methods 0.000 description 1
102000030592 phosphoserine aminotransferase Human genes 0.000 description 1
108010088694 phosphoserine aminotransferase Proteins 0.000 description 1
230000000704 physical effect Effects 0.000 description 1
230000008488 polyadenylation Effects 0.000 description 1
108091033319 polynucleotide Proteins 0.000 description 1
102000040430 polynucleotide Human genes 0.000 description 1
239000002157 polynucleotide Substances 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
230000013823 prenylation Effects 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
229940002612 prodrug Drugs 0.000 description 1
239000000651 prodrug Substances 0.000 description 1
210000001236 prokaryotic cell Anatomy 0.000 description 1
108020003519 protein disulfide isomerase Proteins 0.000 description 1
238000001742 protein purification Methods 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
210000001938 protoplast Anatomy 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
108010048484 radixin Proteins 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000006798 recombination Effects 0.000 description 1
238000005215 recombination Methods 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000033458 reproduction Effects 0.000 description 1
230000001850 reproductive effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
108091008146 restriction endonucleases Proteins 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
238000004366 reverse phase liquid chromatography Methods 0.000 description 1
239000002342 ribonucleoside Substances 0.000 description 1
108010092942 ribosomal protein S20 Proteins 0.000 description 1
229930182490 saponin Natural products 0.000 description 1
150000007949 saponins Chemical class 0.000 description 1
235000017709 saponins Nutrition 0.000 description 1
CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000028327 secretion Effects 0.000 description 1
238000000926 separation method Methods 0.000 description 1
210000002966 serum Anatomy 0.000 description 1
239000008159 sesame oil Substances 0.000 description 1
235000011803 sesame oil Nutrition 0.000 description 1
230000014639 sexual reproduction Effects 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
238000002741 site-directed mutagenesis Methods 0.000 description 1
239000011734 sodium Substances 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
239000001509 sodium citrate Substances 0.000 description 1
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
238000005063 solubilization Methods 0.000 description 1
230000007928 solubilization Effects 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
238000010186 staining Methods 0.000 description 1
239000008223 sterile water Substances 0.000 description 1
230000004936 stimulating effect Effects 0.000 description 1
239000011550 stock solution Substances 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
YOEWQQVKRJEPAE-UHFFFAOYSA-L succinylcholine chloride (anhydrous) Chemical compound [Cl-].[Cl-].C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C YOEWQQVKRJEPAE-UHFFFAOYSA-L 0.000 description 1
231100000617 superantigen Toxicity 0.000 description 1
238000002198 surface plasmon resonance spectroscopy Methods 0.000 description 1
230000008685 targeting Effects 0.000 description 1
235000012976 tarts Nutrition 0.000 description 1
ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
238000011287 therapeutic dose Methods 0.000 description 1
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 1
229940033663 thimerosal Drugs 0.000 description 1
231100000419 toxicity Toxicity 0.000 description 1
230000001988 toxicity Effects 0.000 description 1
230000005026 transcription initiation Effects 0.000 description 1
230000037317 transdermal delivery Effects 0.000 description 1
238000001890 transfection Methods 0.000 description 1
238000012546 transfer Methods 0.000 description 1
230000014621 translational initiation Effects 0.000 description 1
230000005945 translocation Effects 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
108010093459 tubulin-specific chaperone C Proteins 0.000 description 1
229940035936 ubiquinone Drugs 0.000 description 1
OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
241000701447 unidentified baculovirus Species 0.000 description 1
238000002255 vaccination Methods 0.000 description 1
108700026220 vif Genes Proteins 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
239000002699 waste material Substances 0.000 description 1
230000003442 weekly effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/4359—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from fleas

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Insects & Arthropods (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Toxicology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
General Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Medicinal Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Tropical Medicine & Parasitology (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Investigating Or Analysing Biological Materials (AREA)

CA002462873A 2001-10-10 2002-10-04 Molecules d'acides nucleiques et proteines issues de la tete, de la moelle epiniere, de l'intestin posterieur et du tube de malpighi de puces et utilisations correspondantes Abandoned CA2462873A1 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US32834701P	2001-10-10	2001-10-10
US60/328,347		2001-10-10
PCT/US2002/031878 WO2003031577A2 (fr)	2001-10-10	2002-10-04	Molecules d'acides nucleiques et proteines issues de la tete, de la moelle epiniere, de l'intestin posterieur et du tube de malpighi de puces et utilisations correspondantes

Publications (1)

Publication Number	Publication Date
CA2462873A1 true CA2462873A1 (fr)	2003-04-17

Family

ID=23280610

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002462873A Abandoned CA2462873A1 (fr)	2001-10-10	2002-10-04	Molecules d'acides nucleiques et proteines issues de la tete, de la moelle epiniere, de l'intestin posterieur et du tube de malpighi de puces et utilisations correspondantes

Country Status (4)

Country	Link
EP (1)	EP1578911A2 (fr)
JP (1)	JP2005512520A (fr)
CA (1)	CA2462873A1 (fr)
WO (1)	WO2003031577A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2547381T3 (es)	2004-04-09	2015-10-05	Monsanto Technology, Llc	Composiciones y procedimientos de control de infestaciones de insectos en plantas
BRPI0616181B1 (pt)	2005-09-16	2024-03-05	Monsanto Technology Llc	Construção de polinucleotídeo isolada, sequência de ribonucleotídeo de fita dupla, microrganismo transgênico, seu método de produção, e métodos para controle de infestação por coleóptero praga, para melhorar o rendimento e a tolerância a estiagem de um cultivo, e para produção de um produto comercial, alimento ou ração
CN108366540A (zh)	2015-12-18	2018-08-03	美国陶氏益农公司	赋予对鞘翅目和半翅目害虫的抗性的核糖体蛋白l40(rpl40)核酸分子

2002
- 2002-10-04 CA CA002462873A patent/CA2462873A1/fr not_active Abandoned
- 2002-10-04 JP JP2003534548A patent/JP2005512520A/ja not_active Withdrawn
- 2002-10-04 EP EP02784031A patent/EP1578911A2/fr not_active Withdrawn
- 2002-10-04 WO PCT/US2002/031878 patent/WO2003031577A2/fr not_active Ceased

Also Published As

Publication number	Publication date
JP2005512520A (ja)	2005-05-12
WO2003031577A2 (fr)	2003-04-17
EP1578911A2 (fr)	2005-09-28

Legal Events

Date	Code	Title	Description
2007-10-04	FZDE	Discontinued

Publication	Publication Date	Title
US8268976B2 (en)	2012-09-18	Flea GABA receptor subunit nucleic acid molecules
US20090042230A1 (en)	2009-02-12	Flea allantoinase proteins and uses thereof
EP1578911A2 (fr)	2005-09-28	Molecules d'acides nucleiques et proteines issues de la tete, de la moelle epiniere, de l'intestin posterieur et du tube de malpighi de puces et utilisations correspondantes
US8088903B2 (en)	2012-01-03	Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
US7667019B2 (en)	2010-02-23	Flea ultraspiracle nucleic acid molecules
AU2010200627B2 (en)	2012-02-09	Flea and tick octopamine receptor nucleic acid molecules, proteins and uses thereof
US20050075493A1 (en)	2005-04-07	Flea synaptic vesicle nucleic acid molecules, proteins and uses thereof
US7662622B2 (en)	2010-02-16	Flea peritrophin nucleic acid molecules
AU2002347817A1 (en)	2003-04-22	Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
AU2001296834A1 (en)	2002-06-27	Flea peritrophin nucleic acid molecules, proteins and uses thereof